Key Takeaways
- • Mitsui Chemicals (Tokyo: 4183) launched its second Corporate Venture Capital fund, '321Catalyst™', with a fund size of $60 million and a 10-year life.
- • The fund is managed by a newly established subsidiary, 321Catalyst Ventures, Inc., which operates as an independent fund in the USA.
- • The vehicle follows the 2022 '321FORCE™' fund launched with Japanese venture capital firm Global Brain, and aims to build global innovation partnerships and launch new products and businesses.
- • Investments are aligned with the company's Basic Strategy of 'building solutions-based business models' under its VISION 2030 long-term plan.
Summary
Mitsui Chemicals, Inc., a Tokyo-listed (4183) global chemicals manufacturer, announced the launch of its second corporate venture capital fund, '321Catalyst™', according to a Business Wire release dated May 26, 2025. The fund carries a size of $60 million and a life of 10 years. It will be managed by a newly established subsidiary, 321Catalyst Ventures, Inc., which the company describes as an independent fund established in the United States.
The fund builds on the company's first corporate venture vehicle, '321FORCE™', launched in 2022 together with Japanese venture capital firm Global Brain. The stated mission of 321Catalyst™ is to accelerate global innovation partnerships and the launch of new products and businesses. The company said that strong innovation partnerships with portfolio companies would allow it to launch new businesses ahead of competitors.
The release frames the fund as part of the company's strategy to expand global investment in innovative startups that align with its strategic focus. It links the initiative to its Basic Strategy of 'building solutions-based business models' under its Long-Term Business Plan, VISION 2030. Mitsui Chemicals said it will continue investing in startups worldwide to accelerate new product and business launches and to transform its business portfolio. The release was issued by President and CEO HASHIMOTO Osamu.
The fund builds on the company's first corporate venture vehicle, '321FORCE™', launched in 2022 together with Japanese venture capital firm Global Brain. The stated mission of 321Catalyst™ is to accelerate global innovation partnerships and the launch of new products and businesses. The company said that strong innovation partnerships with portfolio companies would allow it to launch new businesses ahead of competitors.
The release frames the fund as part of the company's strategy to expand global investment in innovative startups that align with its strategic focus. It links the initiative to its Basic Strategy of 'building solutions-based business models' under its Long-Term Business Plan, VISION 2030. Mitsui Chemicals said it will continue investing in startups worldwide to accelerate new product and business launches and to transform its business portfolio. The release was issued by President and CEO HASHIMOTO Osamu.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.